NASDAQ: CRNCCerence Inc Stock
$9.39-0.66 (-6.57%)
Updated Apr 25, 2024
CRNC Price
$9.39
Fair Value Price
$2.06
Market Cap
$391.32M
52 Week Low
$9.35
52 Week High
$36.79
P/E
-12.19x
P/B
0.54x
P/S
2.32x
PEG
N/A
Dividend Yield
N/A
Revenue
$349.15M
Earnings
-$30.24M
Gross Margin
72.7%
Operating Margin
10.66%
Profit Margin
-8.7%
Debt to Equity
0.73
Operating Cash Flow
$7M
Beta
1.41
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
CRNC Overview
Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market worldwide. The company offers edge software components; cloud-connected components and related toolkits and applications; and virtual assistant coexistence and professional services. It also provides conversational artificial intelligence-based solutions, including speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence Inc. is headquartered in Burlington, Massachusetts.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CRNC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CRNC ($9.39) is overvalued by 356.1% relative to our estimate of its Fair Value price of $2.06 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CRNC ($9.39) is not significantly undervalued (356.1%) relative to our estimate of its Fair Value price of $2.06 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CRNC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CRNC due diligence checks available for Premium users.
Be the first to know about important CRNC news, forecast changes, insider trades & much more!
CRNC News
Valuation
CRNC fair value
Fair Value of CRNC stock based on Discounted Cash Flow (DCF)
Price
$9.39
Fair Value
$2.06
Overvalued by
356.10%
CRNC ($9.39) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CRNC ($9.39) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CRNC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CRNC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-12.19x
Industry
101.91x
Market
40.97x
CRNC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.54x
Industry
6.49x
CRNC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CRNC's financial health
Profit margin
Revenue
$138.3M
Net Income
$23.9M
Profit Margin
17.2%
CRNC's Earnings (EBIT) of $37.21M... subscribe to Premium to read more.
Interest Coverage Financials
CRNC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.3B
Liabilities
$533.8M
Debt to equity
0.73
CRNC's short-term assets ($228.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRNC's long-term liabilities ($413.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRNC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.8M
Investing
$1.2M
Financing
-$130.0k
CRNC's operating cash flow ($6.80M)... subscribe to Premium to read more.
Debt Coverage Financials
CRNC vs App Stocks
Cerence Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.